Nanobody works against all SARS-CoV-2 variants of concern in animal model
Nanobody works against all SARS-CoV-2 variants of concern in animal model Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains. A pre-print version of the research paper is available to read in full on the Antibody immunity Vacc...
Source: news-medical.net